Clinical Study
BNP and Admission Glucose as In-Hospital Mortality Predictors in Non-ST Elevation Myocardial Infarction
Table 1
Clinical and demographic patient characteristics, grouped by blood glucose ≥ or < 200 mg/dL.
| | All | Glucose < 200 mg/dL | Glucose ≥ 200 mg/dL | |
| | Patients, (%) | 96 | 77 (80.2) | 19 (19.8) | | | Age (years)* | 65.1 (11.7) | 64.9 (12.0) | 65.7 (10.7) | 0.791 | | Male, (%) | 64 (66.7) | 59 (76.6) | 5 (26.3) | <0.001 | | Prior coronary artery disease, (%) | 57 (59.4) | 43 (55.8) | 14 (73.7) | 0.156 | | Hypertension, (%) | 86 (89.6) | 67 (87.0) | 19 (100) | 0.097 | | Current smoker, (%) | 16 (16.7) | 13 (16.7) | 3 (15.8) | 0.909 | | Dyslipidemia, (%) | 65 (67.7) | 53 (68.8) | 12 (63.2) | 0.636 | | Diabetes mellitus, (%) | 48 (50) | 30 (38.9) | 18 (94.7) | <0.001 | | Family history of coronary artery disease, (%) | 35 (36.5) | 29 (37.7) | 6 (31.6) | 0.622 | | Heart rate (beats/minute) | 82.6 (27.6) | 77.3 (71.9) | 102.7 (86.4) | <0.001 | | Systolic blood pressure (mmHg) | 137.5 (30.8) | 140.2 (29.6) | 127.8 (33.7) | 0.121 | | Diastolic blood pressure (mmHg) | 83.1 (17.1) | 84.8 (16.6) | 76.8 (17.6) | 0.072 | | Killip > I, (%) | 19 (19.8) | 10 (13.0) | 9 (47.4) | <0.001 | | Admission glucose (mg/dL) | 152.4 (100.0) | 113.1 (31.8) | 311.9 (122.8) | <0.001 | | BNP (pg/mL) | 358.3 (381.0) | 283.7 (339.3) | 660.8 (399.4) | <0.001 | | Hemoglobin (g/dL) | 13.5 (2.1) | 13.9 (1.9) | 11.8 (2.2) | <0.001 | | White blood cell count (/mm3) | 9879.6 (3418.4) | 9437.3 (3181.0) | 11722.2 (3838.3) | 0.010 | | Platelet count (/mm3) | 235244.7 (82837.8) | 221118.0 (73987.4) | 294889.0 (93436.3) | <0.001 | | Serum urea (mg/dL) | 52.7 (29.4) | 49.5 (25.9) | 65.5 (38.6) | 0.033 | | Serum creatinine (mg/dL) | 1.33 (1.00) | 1.20 (0.48) | 1.81 (1.98) | 0.016 | | Creatinine kinase-MB (CKMB) peak (ng/mL) | 65.1 (111.1) | 73.2 (119.5) | 32.5 (58.7) | 0.154 | | Troponin I (ng/mL) | 25.8 (40.6) | 26.5 (41.9) | 23.1 (35.6) | 0.741 | | Cholesterol (mg/dL) | 175.0 (39.4) | 174.7 (39.7) | 176.4 (39.3) | 0.892 | | HDL-C (mg/dL) | 41.0 (10.9) | 40.9 (10.9) | 41.5 (11.2) | 0.872 | | LDL-C (mg/dL) | 110.6 (32.5) | 110.0 (32.9) | 113.4 (321.2) | 0.732 | | Triglycerides (mg/dL) | 130.4 (76.2) | 129.2 (72.4) | 136.0 (95.9) | 0.772 | | Ejection fraction (%) | 44.7 (15.3) | 46.4 (14.3) | 39.4 (17.4) | 0.083 | | Angiography, (%) | 86 (89.6) | 72 (93.5) | 14 (73.7) | 0.011 | | Medical therapy, (%) | 35 (36.5) | 26 (33.8) | 9 (47.4) | 0.270 | | Percutaneous coronary intervention, (%) | 49 (57.0) | 43 (59.7) | 6 (42.9) | 0.243 | | Surgery, (%) | 12 (12.5) | 8 (10.4) | 4 (21.0) | 0.208 | | Length of stay (days) | 10.5 (18.6) | 7.4 (12.9) | 22.8 (30.2) | <0.001 | | Followup (months) | 21.7 (9.7) | 22.5 (8.7) | 18.2 (12.8) | 0.084 | | Mortality, (%) | 17 (17.7) | 11 (14.3) | 6 (31.6) | 0.077 | | In-hospital, (%) | 7 (7.3) | 2 (2.6) | 5 (26.3) | <0.001 | | Followup, (%) | 10 (11.2) | 9 (12.0) | 1 (7.1) | 0.597 | | In-hospital mortality + prolonged length of stay, (%) | 25 (26.0) | 13 (16.9) | 12 (63.2) | <0.001 | | Follow-up mortality + readmission, (%) | 51 (57.3) | 43 (57.3) | 8 (57.1) | 0.989 |
|
|
